Interview with Germano Carganico, General Manager, Toscana Life Sciences
Italians are often praised to make up deficiencies of the country at national level with more creativity at a regional level- which is why Science Parks are coordinated at the…
Address: Via Fiorentina, 1 , 53100 Siena,Italy
Tel: +39 0577 231211
Web: http://www.toscanalifesciences.info/it/
Toscana Life Sciences (TLS) consists of both a Science park and a foundation.
TLS foundation is a non-profit organization founded in December 2004 by a group of public and private institutions in Tuscany, including the Province and Municipality of Siena, the Tuscany Region, the Monte Paschi Bank and Monte Paschi Foundation, the Chamber of Commerce of Siena, the Universities of Florence, Siena and Pisa, the Scuola Normale and Scuola St. Anna of Pisa, and the Hospital of Siena.
The Science Park represents the most important project of the TLS Foundation; its main aim is to offer equipped buildings, services and financing opportunities, thus creating a fertile ground for the development of new biotech companies focused on pharmaceutical, biotech, diagnostic and innovative biomedical technologies.
Besides the equipped labs and office rental, the TLS Science Park provides incubated companies with a full package of services, ranging from General Services, linked to day-to-day research activities, to Consultancy Services in line with company business management needs.
Italians are often praised to make up deficiencies of the country at national level with more creativity at a regional level- which is why Science Parks are coordinated at the…
Molteni was created in 1892 and progressively developed a strong manufacturing base, a very active R&D department and a growing international presence. Could you introduce the story behind such achievements?…
You declared in a recent interview that Zambon Group will always keep complying with the vision of your father Alberto, who has always refused acquisition offers from multinationals- a striking…
You are specialised in Cardiology at Padua University, in Tropical Medicine and Hygiene at London University and in Pharmacology at Modena University, in Communication at Bocconi University in Milan, and…
Recordati was created in 1926, and the combined work of three generations turned the small laboratory not only into a local success story but also a broad European Group. Your…
Having led a 26 years long career in Pfizer, you have been involved in a number of different countries including leading markets such as the US and Japan, but also…
You have worked in other countries such as the UK and the US with very large and significant pharmaceutical industries. What would you say is particular about the Italian pharmaceutical…
Since 1982, CNR has been the Italian public body which most contributed to the creation of inventions and innovations. What have been the main strategies behind such a success in…
Over more than 25 years, PAREXEL has expanded its global footprint through a combination of organic growth, alliances, and acquisitions. What was the rationale behind entering Italy in 1995 and…
Roche Italy is one of the companies which went through the most significant re-organization process in the country in the past three years- with important changes in both its marketing…
When you were appointed General Director of the Agenzia Italiana del Farmaco (AIFA) in 2007, the dedicated Investigation Commission highlighted the need for an in-depth reorganization of the Agency in…
When you became President of Sankyo Pharma Italy in 2003 one of your objectives was to maximize sales of the existing portfolio- and the company’s sales have impressively tripled in…
Intermediate distribution plays a crucial role in establishing bridges between industrial production and final delivery to patients- and in Italy, this function is executed with highly contained costs and commercial…
See our Cookie Privacy Policy Here
